Keyphrases
B7-H1
85%
Programmed Death-ligand 1 (PD-L1)
84%
Tumor
43%
T Cells
38%
CD8+ T Cells
33%
Renal Cell Carcinoma
31%
Tumor Immunity
24%
B7-H1 Expression
23%
Costimulatory Molecules
22%
Dendritic Cells
14%
Tumor Cells
13%
Immune Response
13%
Apoptosis
10%
T Cell Activation
10%
Lectin
9%
Chemotherapy
9%
Extracellular Vesicles
8%
B7 Family
8%
PD-L1 Inhibitor
8%
T Cell Response
8%
B7-H3
8%
Metastatic Renal Cell Carcinoma (mRCC)
8%
Effector Memory T Cells
7%
Monocytes
7%
Thymocytes
7%
Costimulation
7%
Clear Cell Renal Cell Carcinoma (ccRCC)
7%
Nephrectomy
7%
PD-1 Blockade
7%
Therapeutic Vaccine
7%
Tumor Growth
7%
Tumor-associated
6%
Metastatic Melanoma
6%
Cancer-specific Survival
6%
Cancer Cells
6%
Soluble PD-L1 (sPD-L1)
6%
Cytotoxicity
6%
Poor Prognosis
6%
Patient Survival
5%
Effector Cells
5%
CD8+
5%
Cancer Immunotherapy
5%
Risk Ratio
5%
Non-small Cell Lung Cancer (NSCLC)
5%
Tumor-derived Extracellular Vesicles
5%
Interleukin-10
5%
Immune Evasion
5%
Thymic Dendritic Cell
5%
NF-B
5%
Clinical Outcomes
5%
Immunology and Microbiology
T Cell
100%
Cytotoxic T-Cell
55%
Programmed Death-Ligand 1
39%
Carcinoma Cell
29%
Immunotherapy
27%
Dendritic Cell
27%
Mouse
26%
Programmed Death 1 Ligand 1
23%
Tumor Cell
23%
Immunocompetent Cell
15%
Immune Response
14%
Monocyte
12%
Lymphocyte
12%
Cell Death
11%
Upregulation
11%
CD8
11%
T-Helper Cell
11%
Cytotoxicity
11%
Monospecific Antibody
9%
Interleukin 10
8%
Macrophage
8%
Tumor Immunity
8%
CD28
7%
Thymocyte
7%
Lectin
7%
Prostate
7%
interferon
7%
Immunosuppressive Drug
7%
Vaccination Policy
6%
B Cell
6%
Cell Surface
6%
T Cell Proliferation
6%
Regulatory T Cell
6%
Cancer Immunotherapy
6%
Antigen Specificity
6%
Secretion (Process)
6%
Knockout Mouse
6%
Adoptive Immunity
6%
Immune Checkpoint Blockade
6%
Effector Cell
6%
Cancer Cell
6%
Tumor-Infiltrating Lymphocytes
6%
Immune Evasion
5%
Interleukin 2
5%
Pokeweed Mitogen
5%
Exosome
5%
CD4
5%
T Cell Receptor
5%
T Cell Activation
5%
Lymph Node
5%
Medicine and Dentistry
Neoplasm
68%
Clear Cell Renal Cell Carcinoma
40%
T Cell
38%
Immunotherapy
26%
Programmed Death-Ligand 1
19%
Programmed Death 1 Ligand 1
17%
Tumor Cell
15%
Immune Checkpoint Inhibitor
15%
Cytotoxic T-Cell
14%
Malignant Neoplasm
14%
Programmed Cell Death
13%
Metastatic Carcinoma
10%
Cholangiocarcinoma
10%
Metastatic Melanoma
9%
Adenocarcinoma
9%
Nephrectomy
8%
Biological Marker
8%
T-Cell Response
8%
Overall Survival
8%
Pembrolizumab
8%
Lymphocyte
7%
Radiation Therapy
7%
Immunosuppressive Drug
7%
Immunocompetent Cell
7%
Myeloid-Derived Suppressor Cell
7%
Cellular Immunity
7%
Interleukin 10
6%
Nodular Melanoma
6%
Disease
6%
Cancer Therapy
6%
Primary Tumor
6%
Secretion (Process)
6%
Programmed Death 1 Receptor
6%
Non Small Cell Lung Cancer
5%
Paclitaxel
5%
Immune Evasion
5%
Cancer Cell
5%
Cancer Specific Survival
5%
Mesothelioma
5%
Tumor Vascularization
5%
Prostate Cancer
5%
COVID-19
5%
Chemoimmunotherapy
5%
